Characteristics of children hospitalized with severe asthma in southern Brazil <b>[Abstract in English]</b>
Keywords:
ASTHMA/epidemiology, HOSPITALIZATION/statistics & numerical data, CHILD, INFANT, PRESCHOOL, CROSS-SECTIONAL STUDIES, RETROSPECTIVE STUDIES.Abstract
AIMS: To describe the cases of pediatric hospitalizations of asthma exacerbations, discussing clinical and epidemiological factors involved. METHODS: Retrospective cross-sectional study of hospitalizations in patients younger than 18 years, between January and December of 2009, in a hospital of the Southern Region of Brazil. Characteristics of the patients, hospitalization data, medications used, and outcomes were recorded. RESULTS: Seventy-four children were hospitalized with severe asthma, with median age 3.2 years (standard deviation 2.8), of whom 59.5% were male. We observed that 12% of children used regular therapy with inhaled corticosteroids and 21% had outpatient follow-up with a pediatric pneumologist. The median length of hospital stay was 6 days (standard deviation 7.8), with a maximun of 50 days. Most hospitalizations occurred in August (28.4%). There was one death in the study period. CONCLUSIONS: There was a predominance of hospitalizations in children under three years and the incidence was increased in winter. Low rates of outpatient regular follow-up and use of preventive medication were found. Preventive therapy and educational programs must be encouraged to decrease the incidence of pediatric hospitalization for asthma in Brazil.Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The submission of originals to Scientia Medica implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Scientia Medica as the site of original publication.
Creative Commons License
Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.